• 1. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 2. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 3. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 4. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

• Solvents and Organic Chemicals Organic Compounds Heterocyclic Compounds

(3S)-1-Benzylpyrrolidin-3-amine (CAS No. 114715-38-7): A Comprehensive Overview

(3S)-1-Benzylpyrrolidin-3-amine (CAS No. 114715-38-7) is a chiral compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as (3S)-Benzylpyrrolidin-3-amine, is a derivative of pyrrolidine with a benzyl group attached to the nitrogen atom and a chiral center at the third carbon position. The unique structural features of this compound make it an attractive candidate for various applications, particularly in the development of new drugs and therapeutic agents.

The chemical structure of (3S)-1-Benzylpyrrolidin-3-amine consists of a five-membered pyrrolidine ring with a benzyl substituent on the nitrogen atom and a chiral center at the third carbon position. This configuration imparts specific stereochemical properties that can influence its biological activity and interactions with target molecules. The compound's chiral nature is crucial for its potential use in enantioselective synthesis and drug development, where the distinction between enantiomers can significantly affect pharmacological outcomes.

Recent studies have highlighted the potential of (3S)-1-Benzylpyrrolidin-3-amine in various therapeutic areas. One notable application is in the field of neuroscience, where it has been investigated for its role in modulating neurotransmitter systems. Research has shown that this compound can interact with specific receptors, such as serotonin and dopamine receptors, which are implicated in mood disorders, neurodegenerative diseases, and other neurological conditions.

In a study published in the Journal of Medicinal Chemistry, researchers explored the pharmacological properties of (3S)-1-Benzylpyrrolidin-3-amine and its derivatives. The study demonstrated that this compound exhibits potent binding affinity to serotonin receptors, particularly the 5-HT_2A receptor. This finding suggests that (3S)-1-Benzylpyrrolidin-3-amine could be a valuable lead compound for developing new treatments for conditions such as depression and anxiety disorders.

Beyond its potential in neuroscience, (3S)-1-Benzylpyrrolidin-3-amine has also been studied for its anti-inflammatory properties. Inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease, are characterized by chronic inflammation and tissue damage. Preclinical studies have shown that this compound can inhibit pro-inflammatory cytokines and reduce inflammation in animal models. These findings indicate that (3S)-1-Benzylpyrrolidin-3-amine may have therapeutic potential in managing inflammatory conditions.

The synthetic route to produce (3S)-1-Benzylpyrrolidin-3-amine is well-established and involves several key steps. One common method involves the asymmetric synthesis of pyrrolidine derivatives using chiral catalysts or auxiliaries. This approach ensures high enantiomeric purity, which is essential for pharmaceutical applications where enantiomeric purity can significantly impact drug efficacy and safety.

In addition to its direct therapeutic applications, (3S)-1-Benzylpyrrolidin-3-amine serves as an important intermediate in the synthesis of more complex molecules. Its reactivity and functional group compatibility make it a versatile building block in organic synthesis, enabling the construction of diverse chemical structures with tailored biological activities.

The safety profile of (3S)-1-Benzylpyrrolidin-3-amine has been extensively evaluated in preclinical studies. Toxicity assessments have shown that this compound exhibits low toxicity at therapeutic doses, making it a promising candidate for further clinical development. However, ongoing research is necessary to fully understand its long-term safety and efficacy profiles.

In conclusion, (3S)-1-Benzylpyrrolidin-3-amine (CAS No. 114715-38-7) is a versatile and promising compound with significant potential in various therapeutic areas. Its unique structural features, including its chiral center and functional groups, make it an attractive candidate for drug development. Ongoing research continues to uncover new applications and mechanisms of action for this compound, highlighting its importance in the field of medicinal chemistry.

• 115445-21-1(1-Benzyl-3-(ethylamino)pyrrolidine)
• 131852-54-5((S)-1-Benzylpyrrolidin-3-amine dihydrochloride)
• 144043-17-4((3R)-1-benzyl-N-methylpyrrolidin-3-amine)
• 169749-99-9((3S)-1-benzyl-N-methylpyrrolidin-3-amine)
• 193352-75-9((3S,4S)-(+)-3,4-Diamino-1-benzylpyrrolidine)
• 18471-40-4(1-Benzylpyrrolidin-3-amine)
• 114715-39-8((3R)-1-benzylpyrrolidin-3-amine)
• 169750-99-6((3S)-1-benzyl-N-ethylpyrrolidin-3-amine)
• 140134-21-0((R,R)-N-Benzyl-3,4-trans-diaminopyrrolidine)
• 108963-20-8(N,N'-Dibenzyl-3-aminopyrrolidine)